Welcome to CDC stacks | Hemolytic Uremic Syndrome Associated with Escherichia coli O8:H19 and Shiga Toxin 2f Gene - 26668 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Hemolytic Uremic Syndrome Associated with Escherichia coli O8:H19 and Shiga Toxin 2f Gene
Filetype[PDF-279.20 KB]


No Related Documents.
You May Also Like:
  1. Burkholderia pseudomallei Sequence Type 562 in China and Australia
    Personal Author:
    Chen, Hai; Xia, Lianxu; Zhu, Xiong; Li, Wei; Du, Xiaoli; Wu, Duorong; Hai, Rong; Shen, Xiaona; Liang, Ying; Cai, Hong; Zheng, Xiao;
    Published:
    2015
    Source:
    Emerg Infect Dis. 21(1):166-168.
    File Type:
    Filetype[PDF - 375.16 KB]
  2. Whole-Genome Characterization and Strain Comparison of VT2f-Producing Escherichiacoli Causing Hemolytic Uremic Syndrome
    Personal Author:
    Grande, Laura; Michelacci, Valeria; Bondì, Roslen; Gigliucci, Federica; Franz, Eelco; Badouei, Mahdi Askari; Schlager, Sabine; Minelli, Fabio; Tozzoli, Rosangela; Caprioli, Alfredo; Morabito, Stefano;
    Published:
    Dec 15 2016
    Source:
    Emerg Infect Dis. 22(12):2078-2086.
    Description:
    Verotoxigenic Escherichia coli infections in humans cause disease ranging from uncomplicated intestinal illnesses to bloody diarrhea and systemic sequelae, such as hemolytic uremic syndrome (HUS). Previous research indicated that pigeons may be a res...
    File Type:
    Filetype[PDF - 1.42 MB]
  3. Secondary Shiga Toxin–Producing Escherichia coli Infection, Japan, 2010–2012
    Personal Author:
    Morita-Ishihara, Tomoko; Iyoda, Sunao; Iguchi, Atsushi; Ohnishi, Makoto;
    Published:
    Dec 2016
    Source:
    Emerg Infect Dis. 22(12):2181-2184.
    Description:
    To evaluate the potential public health risk caused by secondary Shiga toxin-producing Escherichia coli (STEC) infections in Japan, we investigated the prevalence and characteristics of STEC isolated from healthy adults during 2010-2012. Although pre...
    File Type:
    Filetype[PDF - 487.61 KB]
  4. Guidance for public health laboratories : isolation and characterization of Shiga toxin-producing Escherichia coli (STEC) from clinical specimens
    Corporate Author:
    Association of Public Health Laboratories. STEC Work Group..; Centers for Disease Control and Prevention (U.S.);
    Published:
    April 2012
    Description:
    Clinical laboratories are the front line in detecting Shiga toxin-producing Escherichia coli (STEC) disease. They are responsible for the initial detection of suspect cases by testing primary specimens. In October 2009, a report entitled “Recommend...
    File Type:
    Filetype[PDF - 5.61 MB]
  5. Human Infections with Non-O157 Shiga Toxin–producing Escherichia coli, Switzerland, 2000–2009
    Personal Author:
    Käppeli, Ursula; Hächler, Herbert; Giezendanner, Nicole; Beutin, Lothar; Stephan, Roger;
    Published:
    Feb 2011
    Source:
    Emerg Infect Dis. 17(2):180-185.
    Description:
    We characterized 97 non-O157 Shiga toxin (stx)-producing Escherichia coli strains isolated from human patients during 2000-2009 from the national reference laboratory in Switzerland. These strains belonged to 40 O:H serotypes; 4 serotypes (O26:H11/H-...
    File Type:
    Filetype[PDF - 160.93 KB]